临床试验

Vercise™ DBS Dystonia Prospective Study

NCT：NCT02686125 · RECRUITING

NCT编号NCT02686125

状态RECRUITING

开始日期2016-03-07

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2016-02-19

Last updated2026-09-11

简要摘要

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。